Clinical Trial Update: Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada [Phase 4]

View source ↗

Summary

Phase 4 Canadian study evaluating the efficacy and tolerability of AZARGA as a replacement therapy for patients on COMBIGAN, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Azarga (brinzolamide; timolol maleate)
• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-07-01